AIRLINK 80.55 Increased By ▲ 1.14 (1.44%)
BOP 5.28 Decreased By ▼ -0.05 (-0.94%)
CNERGY 4.39 Increased By ▲ 0.01 (0.23%)
DFML 34.79 Increased By ▲ 1.60 (4.82%)
DGKC 76.90 Increased By ▲ 0.03 (0.04%)
FCCL 20.65 Increased By ▲ 0.12 (0.58%)
FFBL 33.50 Increased By ▲ 2.10 (6.69%)
FFL 9.75 Decreased By ▼ -0.10 (-1.02%)
GGL 10.20 Decreased By ▼ -0.05 (-0.49%)
HBL 118.45 Increased By ▲ 0.52 (0.44%)
HUBC 135.60 Increased By ▲ 1.50 (1.12%)
HUMNL 7.04 Increased By ▲ 0.04 (0.57%)
KEL 4.67 No Change ▼ 0.00 (0%)
KOSM 4.70 Decreased By ▼ -0.04 (-0.84%)
MLCF 37.60 Increased By ▲ 0.16 (0.43%)
OGDC 137.00 Increased By ▲ 0.30 (0.22%)
PAEL 23.04 Decreased By ▼ -0.11 (-0.48%)
PIAA 27.17 Increased By ▲ 0.62 (2.34%)
PIBTL 6.91 Decreased By ▼ -0.09 (-1.29%)
PPL 113.40 Decreased By ▼ -0.35 (-0.31%)
PRL 27.49 Decreased By ▼ -0.03 (-0.11%)
PTC 14.75 No Change ▼ 0.00 (0%)
SEARL 57.00 Decreased By ▼ -0.20 (-0.35%)
SNGP 66.67 Decreased By ▼ -0.83 (-1.23%)
SSGC 11.05 Decreased By ▼ -0.04 (-0.36%)
TELE 9.27 Increased By ▲ 0.04 (0.43%)
TPLP 11.58 Increased By ▲ 0.02 (0.17%)
TRG 71.92 Decreased By ▼ -0.18 (-0.25%)
UNITY 25.60 Increased By ▲ 0.78 (3.14%)
WTL 1.36 Decreased By ▼ -0.04 (-2.86%)
BR100 7,590 Increased By 64.4 (0.86%)
BR30 24,769 Increased By 119.8 (0.49%)
KSE100 72,446 Increased By 474.4 (0.66%)
KSE30 23,926 Increased By 177.4 (0.75%)

imageTOKYO: Researchers in Japan have been unable to replicate experiments that were hailed earlier this year as a "game-changer" in the quest to grow transplant tissue, amid claims evidence was faked, a report said Wednesday.

In a scandal that rocked Japan's scientific establishment, Riken -- a research institute that sponsored the study -- launched an independent experiment in April to verify research published by scientist Haruko Obokata and her colleagues earlier this year.

But the struggle to replicate the experiment casts further doubt on the existence of stem cell-like cells, what the researchers called Stimulus-Triggered Acquisition of Pluripotency (STAP) cells, Japan's Nikkei daily reported.

Obokata was feted after unveiling findings that appeared to show a straightforward way to re-programme adult cells to become stem cells -- precursors that are capable of developing into any other cell in the human body.

Identifying a readily manufacturable supply of stem cells could one day help meet a need for transplant tissues, or even whole organs, meaning that any advance in the field is met with excitement in the scientific community.

But after being accused of fabricating results, she agreed to retract papers published in the respected journal Nature.

Earlier this month, Obokata's co-author, stemcell scientist Yoshiki Sasai, hanged himself.

Researchers have been trying to replicate results appearing to show that exposing ordinary cells to various stresses had made them pluripotent, or able to differentiate into any type of tissue.

Riken had planned to implant these cells into mouse embryos to test whether they really were pluripotent.

But the experiments have been fraught with difficulty from the outset, with researchers unable to reproduce such cells, the Nikkei said, citing unnamed sources.

Obokata has been trying in tandem to reproduce her own results since July, but the existence of the STAP cells at this point looks highly doubtful, the Nikkei said.

Riken is to release an interim report on the follow-up study and announce a shake-up of the developmental biology centre in a Wednesday news conference, where it is expected to slash its staff of around 400 researchers by half.

Copyright AFP (Agence France-Presse), 2014

Comments

Comments are closed.